Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GPCR |
---|---|---|
09:32 ET | 132545 | 56.295 |
09:34 ET | 86320 | 56.62 |
09:36 ET | 103882 | 55.66 |
09:38 ET | 144287 | 55 |
09:39 ET | 119939 | 55.06 |
09:41 ET | 80078 | 55.385 |
09:43 ET | 51920 | 55.18 |
09:45 ET | 42369 | 55.025 |
09:48 ET | 99224 | 55.04 |
09:50 ET | 109955 | 54.755 |
09:52 ET | 73929 | 53.73 |
09:54 ET | 115573 | 54.285 |
09:56 ET | 25262 | 54.125 |
09:57 ET | 74848 | 53.55 |
09:59 ET | 84751 | 54 |
10:01 ET | 17060 | 54.58 |
10:03 ET | 65971 | 54.675 |
10:06 ET | 92133 | 54.6318 |
10:08 ET | 14861 | 54.72 |
10:10 ET | 17014 | 54.65 |
10:12 ET | 11006 | 54.77 |
10:14 ET | 48579 | 55 |
10:15 ET | 28781 | 55.03 |
10:17 ET | 16206 | 55 |
10:19 ET | 135854 | 55 |
10:21 ET | 18246 | 55.03 |
10:24 ET | 42607 | 55.245 |
10:26 ET | 14222 | 55.475 |
10:28 ET | 15377 | 55.38 |
10:30 ET | 9571 | 55.5 |
10:32 ET | 73053 | 55.78 |
10:33 ET | 10614 | 55.645 |
10:35 ET | 52391 | 56.68 |
10:37 ET | 18763 | 56.59 |
10:39 ET | 7203 | 56.43 |
10:42 ET | 25620 | 56.51 |
10:44 ET | 15211 | 56.6 |
10:46 ET | 22481 | 57.09 |
10:48 ET | 45930 | 57.08 |
10:50 ET | 13813 | 57.375 |
10:51 ET | 28169 | 57.27 |
10:53 ET | 13725 | 57.325 |
10:55 ET | 11257 | 57.275 |
10:57 ET | 25628 | 57.52 |
11:00 ET | 12389 | 57.52 |
11:02 ET | 31400 | 57.5 |
11:04 ET | 23190 | 57.385 |
11:06 ET | 19347 | 56.91 |
11:08 ET | 13337 | 56.98 |
11:09 ET | 7031 | 56.99 |
11:11 ET | 5661 | 56.99 |
11:13 ET | 11217 | 56.765 |
11:15 ET | 20014 | 56.54 |
11:18 ET | 2731 | 56.49 |
11:20 ET | 10386 | 56.73 |
11:22 ET | 7017 | 56.96 |
11:24 ET | 10168 | 56.8478 |
11:26 ET | 14812 | 56.44 |
11:27 ET | 16359 | 56.04 |
11:29 ET | 10583 | 55.705 |
11:31 ET | 2200 | 55.79 |
11:33 ET | 8537 | 55.855 |
11:36 ET | 14743 | 55.8 |
11:38 ET | 5857 | 55.205 |
11:40 ET | 8371 | 55.565 |
11:42 ET | 13543 | 55.8 |
11:44 ET | 4210 | 55.4 |
11:45 ET | 3983 | 55.28 |
11:47 ET | 10704 | 55.42 |
11:49 ET | 3941 | 55.41 |
11:51 ET | 8648 | 55.31 |
11:54 ET | 3175 | 55.185 |
11:56 ET | 8643 | 55.17 |
11:58 ET | 3025 | 55.16 |
12:00 ET | 16882 | 55.3 |
12:02 ET | 22932 | 55.05 |
12:03 ET | 25289 | 55 |
12:05 ET | 4558 | 55.1425 |
12:07 ET | 24554 | 55.6 |
12:09 ET | 3766 | 55.625 |
12:12 ET | 4699 | 55.55 |
12:14 ET | 2200 | 55.58 |
12:16 ET | 1400 | 55.6 |
12:18 ET | 6733 | 55.72 |
12:20 ET | 6831 | 55.7 |
12:21 ET | 11573 | 55.695 |
12:23 ET | 500 | 55.56 |
12:25 ET | 3583 | 55.66 |
12:27 ET | 800 | 55.76 |
12:30 ET | 3082 | 55.67 |
12:32 ET | 5936 | 55.73 |
12:34 ET | 859 | 55.68 |
12:36 ET | 1522 | 55.7 |
12:38 ET | 3967 | 55.64 |
12:39 ET | 7360 | 55.6 |
12:41 ET | 3530 | 55.525 |
12:43 ET | 2000 | 55.49 |
12:45 ET | 6100 | 55.52 |
12:48 ET | 2405 | 55.515 |
12:50 ET | 10382 | 55.62 |
12:52 ET | 3388 | 55.8 |
12:54 ET | 4012 | 55.78 |
12:56 ET | 5745 | 55.665 |
12:57 ET | 1400 | 55.69 |
12:59 ET | 3710 | 55.585 |
01:01 ET | 7920 | 55.58 |
01:03 ET | 1500 | 55.5 |
01:06 ET | 2508 | 55.55 |
01:08 ET | 30128 | 55.21 |
01:10 ET | 22730 | 55 |
01:12 ET | 32485 | 55.085 |
01:14 ET | 6588 | 55.145 |
01:15 ET | 3225 | 55.125 |
01:17 ET | 13938 | 55.295 |
01:19 ET | 2400 | 55.205 |
01:21 ET | 5123 | 55.28 |
01:24 ET | 600 | 55.22 |
01:26 ET | 3673 | 55.34 |
01:28 ET | 2706 | 55.22 |
01:30 ET | 8337 | 55.06 |
01:32 ET | 2851 | 54.965 |
01:33 ET | 5097 | 55.045 |
01:35 ET | 5244 | 55.185 |
01:37 ET | 3101 | 55.475 |
01:39 ET | 1600 | 55.27 |
01:42 ET | 18691 | 55.04 |
01:44 ET | 4615 | 55.39 |
01:46 ET | 2541 | 55.5 |
01:48 ET | 2561 | 55.54 |
01:50 ET | 9036 | 55.505 |
01:51 ET | 500 | 55.45 |
01:53 ET | 500 | 55.34 |
01:55 ET | 6581 | 55.14 |
01:57 ET | 6685 | 55.24 |
02:00 ET | 1900 | 55.1 |
02:02 ET | 1650 | 55.05 |
02:04 ET | 2125 | 55.0825 |
02:06 ET | 25058 | 55.17 |
02:08 ET | 3677 | 55.28 |
02:09 ET | 2208 | 55.26 |
02:11 ET | 10187 | 55.035 |
02:13 ET | 20348 | 54.945 |
02:15 ET | 2021 | 55.1 |
02:18 ET | 3515 | 55.14 |
02:20 ET | 838 | 55.1 |
02:22 ET | 3427 | 55.12 |
02:24 ET | 2900 | 55.16 |
02:26 ET | 100 | 55.145 |
02:27 ET | 3146 | 55.205 |
02:29 ET | 1295 | 55.205 |
02:31 ET | 1910 | 55.28 |
02:33 ET | 4986 | 55.26 |
02:36 ET | 8104 | 55.1012 |
02:38 ET | 1299 | 55.16 |
02:40 ET | 7956 | 55.22 |
02:42 ET | 2090 | 55.19 |
02:44 ET | 6578 | 55.1 |
02:45 ET | 7026 | 55.101 |
02:47 ET | 1241 | 55.095 |
02:49 ET | 1400 | 55.0875 |
02:51 ET | 3290 | 55.14 |
02:54 ET | 26578 | 55.01 |
02:56 ET | 4062 | 55.01 |
02:58 ET | 7855 | 54.985 |
03:00 ET | 5343 | 55 |
03:02 ET | 5952 | 55.02 |
03:03 ET | 41404 | 55.04 |
03:05 ET | 7162 | 55.1 |
03:07 ET | 16467 | 55.13 |
03:09 ET | 9874 | 55 |
03:12 ET | 3827 | 55.015 |
03:14 ET | 43186 | 55.03 |
03:16 ET | 3857 | 55.075 |
03:18 ET | 5000 | 55.09 |
03:20 ET | 600 | 55.06 |
03:21 ET | 1485 | 55.06 |
03:23 ET | 7282 | 55.11 |
03:25 ET | 2600 | 55.075 |
03:27 ET | 3703 | 55.075 |
03:30 ET | 11410 | 55.26 |
03:32 ET | 3272 | 55.3184 |
03:34 ET | 22686 | 55.525 |
03:36 ET | 4565 | 55.28 |
03:38 ET | 4534 | 55.225 |
03:39 ET | 8015 | 55.425 |
03:41 ET | 14771 | 55.515 |
03:43 ET | 37151 | 55.52 |
03:45 ET | 13225 | 55.38 |
03:48 ET | 5941 | 55.14 |
03:50 ET | 14744 | 55.29 |
03:52 ET | 56591 | 55.645 |
03:54 ET | 37181 | 56 |
03:56 ET | 23489 | 55.8 |
03:57 ET | 19804 | 55.71 |
03:59 ET | 173468 | 55.63 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Structure Therapeutics Inc | 1.6B | -24.0x | --- |
Edgewise Therapeutics Inc | 1.6B | -11.5x | --- |
Neumora Therapeutics Inc | 1.6B | -4.1x | --- |
Kura Oncology Inc | 1.6B | -10.1x | --- |
Syndax Pharmaceuticals Inc | 1.6B | -6.0x | --- |
Sana Biotechnology Inc | 1.7B | -4.8x | --- |
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases. It is focused on G-protein coupled receptors (GPCRs) as a therapeutic target class. Its product candidates include GSBR-1290, Amylin, glucose-dependent insulinotropic polypeptide receptor (GIPR), GCGR, ANPA-0073 and LTSE-2578. It is developing GSBR-1290, its oral small molecule product candidate targeting the validated glucagon-like-peptide-1 receptor (GLP-1R) for the treatment of type 2 diabetes mellitus (T2DM) and obesity. It is developing GLP-1R candidates, including dual GLP-1R/GIPR agonists and amylin agonists, each designed with customized properties to achieve additional benefit. It is developing ANPA-0073, an investigational oral small molecule APJR agonist, for the treatment of idiopathic pulmonary fibrosis (IPF). It is evaluating its LPA1R program, LTSE-2578 for IPF and progressive pulmonary fibrosis.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 46.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.32 |
Book Value | $9.76 |
P/E Ratio | -24.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.